Elekta AB And MSM-MEDIMPEX Enter Agreement To Increase Production Efforts Of Radiotherapy Technology In Russia

Elekta AB and MSM-MEDIMPEX announced their intention to set up production of radiotherapy equipment in Russia, with the intent to improve access to radiation therapy treatments to Russian citizens afflicted with cancer. Russia is the world’s ninth most populous country. The announcement – a Memorandum of Understanding – specifies that Elekta and MSM-MEDIMPEX will work together to manufacture and assemble radiotherapy technology, in addition to a radiotherapy support/service infrastructure in Russia and eventually other Commonwealth of Independent States countries. This effort will amplify national initiatives (such as the National Oncology Program, RNOP, started in 2009) to modernize existing radiotherapy facilities, establish new treatment centers and extend training programs for clinical staff.